|
US3635091A
(en)
*
|
1970-08-31 |
1972-01-18 |
Frederick D Linzer |
Midstream urine specimen and fractional fluid collectors
|
|
IT1074038B
(it)
*
|
1976-08-05 |
1985-04-17 |
Simes |
Esteri della epinina
|
|
US4376110A
(en)
*
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
|
US4357343A
(en)
*
|
1981-06-26 |
1982-11-02 |
Baxter Travenol Laboratories, Inc. |
Nutritional composition for management of renal failure
|
|
US4640909A
(en)
*
|
1985-05-07 |
1987-02-03 |
J. T. Baker Chemical Company |
Bonded phase of silica and carboalkoxyalkyl silanes for solid phase extraction
|
|
US5939272A
(en)
*
|
1989-01-10 |
1999-08-17 |
Biosite Diagnostics Incorporated |
Non-competitive threshold ligand-receptor assays
|
|
JP2912413B2
(ja)
*
|
1990-03-28 |
1999-06-28 |
東亜医用電子株式会社 |
粒度分布作成方法
|
|
US5405832A
(en)
*
|
1991-11-27 |
1995-04-11 |
Immtech International Inc. |
Method of treating non-streptococcal bacterial infections
|
|
US5273961A
(en)
*
|
1992-09-22 |
1993-12-28 |
Genentech, Inc. |
Method of prophylaxis of acute renal failure
|
|
SE9401351D0
(sv)
|
1994-04-21 |
1994-04-21 |
Venge |
A method for diagnosis
|
|
US5552313A
(en)
*
|
1994-11-21 |
1996-09-03 |
Kansas University |
DNA encoding mouse phosphotriesterase-related protein
|
|
US5750345A
(en)
*
|
1995-10-31 |
1998-05-12 |
Evanston Hospital Corporation |
Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
|
|
US5627034A
(en)
*
|
1995-12-05 |
1997-05-06 |
Wisconsin Alumni Research Foundation |
Assay for carcinoma proliferative status by measuring NGAL expression level
|
|
ES2258793T5
(es)
*
|
1996-05-24 |
2010-01-25 |
Biogen Idec Ma Inc. |
Moduladores de la regeneracion tisular.
|
|
WO1999007740A2
(en)
*
|
1997-08-06 |
1999-02-18 |
Zymogenetics, Inc. |
Lipocalin homologs
|
|
US6309888B1
(en)
*
|
1998-09-04 |
2001-10-30 |
Leuven Research & Development Vzw |
Detection and determination of the stages of coronary artery disease
|
|
AUPP784398A0
(en)
*
|
1998-12-21 |
1999-01-21 |
Monash University |
Kidney disease detection and treatment
|
|
WO2000078919A1
(en)
*
|
1999-06-18 |
2000-12-28 |
Michigan State University |
Method and apparatus for the detection of volatile products in a sample
|
|
US6762032B1
(en)
*
|
1999-08-23 |
2004-07-13 |
Biocrystal, Ltd. |
Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
|
|
JP2004510981A
(ja)
*
|
2000-10-03 |
2004-04-08 |
ロウェット、リサーチ、インスティテュート |
ピロール含有生体化合物の測定方法およびピロール含有生体化合物
|
|
WO2002031507A2
(en)
*
|
2000-10-13 |
2002-04-18 |
Children's Medical Center Corporation |
Non-invasive enzyme screen for tissue remodelling-associated conditions
|
|
FI20010019L
(fi)
*
|
2001-01-05 |
2002-07-06 |
Biohit Oyj |
Menetelmä atrofisen diagnostisoimiseksi
|
|
US7713705B2
(en)
*
|
2002-12-24 |
2010-05-11 |
Biosite, Inc. |
Markers for differential diagnosis and methods of use thereof
|
|
US20040203083A1
(en)
*
|
2001-04-13 |
2004-10-14 |
Biosite, Inc. |
Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
|
|
EP1322957B1
(en)
*
|
2001-05-04 |
2009-08-12 |
Biosite Incorporated |
Diagnostic markers of acute coronary syndromes and methods of use thereof
|
|
WO2003029462A1
(en)
*
|
2001-09-27 |
2003-04-10 |
Pieris Proteolab Ag |
Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
|
|
US20030119209A1
(en)
*
|
2001-12-21 |
2003-06-26 |
Kaylor Rosann Marie |
Diagnostic methods and devices
|
|
US6986995B2
(en)
*
|
2002-02-28 |
2006-01-17 |
Prometheus Laboratories, Inc. |
Methods of diagnosing liver fibrosis
|
|
US6847451B2
(en)
*
|
2002-05-01 |
2005-01-25 |
Lifescan, Inc. |
Apparatuses and methods for analyte concentration determination
|
|
GB0215509D0
(en)
*
|
2002-07-04 |
2002-08-14 |
Novartis Ag |
Marker genes
|
|
WO2004048600A2
(en)
*
|
2002-11-22 |
2004-06-10 |
Emory University |
Diagnostic tests and methods for diagnosing inflammatory bowel disease
|
|
US7056702B2
(en)
*
|
2002-12-16 |
2006-06-06 |
Kimberly Clark Co |
Detecting lipocalin
|
|
DE602004022150D1
(de)
*
|
2003-03-27 |
2009-09-03 |
Childrens Hosp Medical Center |
Verfahren und kit zum nachweis des frühstadiums einer nierentubuluszellenverletzung
|
|
US20050148029A1
(en)
*
|
2003-09-29 |
2005-07-07 |
Biosite, Inc. |
Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
|
|
US20050272101A1
(en)
*
|
2004-06-07 |
2005-12-08 |
Prasad Devarajan |
Method for the early detection of renal injury
|
|
CA2565701A1
(en)
*
|
2004-05-06 |
2005-11-17 |
Jonathan M. Barasch |
Ngal for reduction and amelioration of ischemic and nephrotoxic injuries
|
|
CA2511269A1
(en)
*
|
2004-07-07 |
2006-01-07 |
F. Hoffmann-La Roche Ag |
Multimarker panel based on p1gf for diabetes type 1 and 2
|
|
US20060105419A1
(en)
*
|
2004-08-16 |
2006-05-18 |
Biosite, Inc. |
Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions
|
|
ES2818028T3
(es)
*
|
2004-12-20 |
2021-04-09 |
Antibodyshop As |
Determinación de lipocalina asociada a gelatinasa de neutrófilos (NGAL) como marcador diagnóstico para trastornos renales
|
|
US20070037232A1
(en)
*
|
2005-03-31 |
2007-02-15 |
Barasch Jonathan M |
Detection of NGAL in chronic renal disease
|
|
US20080090304A1
(en)
*
|
2006-10-13 |
2008-04-17 |
Barasch Jonathan Matthew |
Diagnosis and monitoring of chronic renal disease using ngal
|
|
PL2035835T3
(pl)
*
|
2006-05-30 |
2012-05-31 |
Antibodyshop As |
Sposoby szybkiej oceny ciężkości urazu
|
|
US20080061149A1
(en)
*
|
2006-09-11 |
2008-03-13 |
Colin Tanner |
Proximity payment card with security interlock
|
|
US20090124022A1
(en)
*
|
2007-10-19 |
2009-05-14 |
Abbott Laboratories |
Antibodies that bind to mammalian ngal and uses thereof
|
|
US20090123970A1
(en)
*
|
2007-10-19 |
2009-05-14 |
Abbott Laboratories |
Glycosylated mammalian ngal and use thereof
|
|
US20090123946A1
(en)
*
|
2007-10-19 |
2009-05-14 |
Abbott Laboratories |
Immunoassays and kits for the detection of ngal
|